LENZ (LENZ Therapeutics) Buildings And Improvements : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Buildings And Improvements?

LENZ Therapeutics Buildings And Improvements Historical Data

The historical data trend for LENZ Therapeutics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Buildings And Improvements Chart

LENZ Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

LENZ Therapeutics Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buildings And Improvements	Get a 7-Day Free Trial					-	-	-	-	-

LENZ Therapeutics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

LENZ Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA, USA, 92075

Website

https://www.lenz-tx.com

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.